- ShiftPixy Inc PIXY announced an agreement in principle with Quelliv, Inc., an exclusive manufacturer, and distributor of the anti-viral biotechnology Genesis One laser device, to better support restaurants and retailers in keeping their businesses and customers safe.
- ShiftPixy has secured exclusive distribution rights for the Genesis One anti-virus laser systems for use in restaurants and retail.
- The company currently intends to offer the anti-viral system to extend its services to current clients initially, with a significant rollout planned for calendar 2022.
- Price Action: PIXY shares are trading higher by 1.77% at $1.15 on the last check Monday.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in
